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The onset of puberty is a milestone marked by 
the appearance and development of secondary 
sexual characteristics and changes in behavior, 
growth, and reproductive capabilities. Changes 
in the timing of pubertal onset and/or progres-
sion have been associated with nutrition, obe-
sity, and environmental contaminants, such as 
heavy metals and endocrine disruptors, sup-
porting an environmental etiology to some 
degree (Buck Louis et al. 2008; Euling et al. 
2008; Parent et al. 2005). Changes in the tim-
ing of onset and/or progression of puberty on 
a national scale have considerable public health 
and social implications for both boys and girls 
(Herman-Giddens 2006). Girls who mature 
relatively earlier are at increased risk of later 
obesity, diabetes, and reproductive-site cancers 
(Golub et al. 2008), and early-maturing girls 
and boys are reported to engage in more risky 
behaviors, such as cigarette smoking, sub-
stance use, and sexual activity (Dunbar et al. 
2008; Hayatbakhsh et al. 2009). Relatively 
late-maturing girls, on the other hand, are at 
risk for diminished bone strength and fragility 
fractures later in life (Chevalley et al. 2009), 
whereas late-maturing boys may be at risk 
for victimization and depressive symptoms 
(Michaud et al. 2006). Assessment of environ-
mental influences on the timing of puberty is 
thus important for health across the human 
life span, whether such influences are associ-
ated with advancements or delays in the onset 
of puberty.
However, few population-based data are 
available to characterize either environmental 
exposures or pubertal onset, contributing to 
our inability to identify environmental threats 
to human development across such sensitive 
windows. In girls, studies have relied primarily 
on physical signs, such as sexual maturation 
staging (Tanner 1962), or age at menarche 
as indicators of pubertal status and timing, 
although such signs are better indicators of later 
pubertal development than of onset (Denham 
et al. 2005; Selevan et al. 2003; Wu et al. 
2003). At the population level, and despite 
claims of a declining secular pattern for puber-
tal onset, few studies have incorporated hor-
monal markers, although these are the clinical 
standard. Such studies are few perhaps because 
of the low expected concentrations in young 
children, the diurnal patterns of hormonal 
secretion, and the insensitivity of most hor-
mones as markers. To address this critical data 
gap, we implemented a hormonal follow-on 
study for a representative sample of girls 6–11 
years of age who participated in the Third 
National Health and Nutrition Examination 
Survey (NHANES III; 1988–1994) and 
for whom blood lead (Pb) and urinary cad-
mium (Cd) concentrations were determined 
(Brody et al. 1994; Paschal et al. 2000; Pirkle 
et al. 1994). We measured concentrations of 
two reproductive hormones—inhibin B and 
luteinizing hormone (LH)—believed to be rel-
evant for younger girls (6–11 years of age) near 
the onset of puberty and that serve as mark-
ers of hypothalamic–pituitary–gonadal func-
tioning. We are unaware of any other research 
aimed at assessing the effect of environmental 
chemicals or metals in relation to pubertal hor-
monal markers to delineate possible   pathways 
of action.
Methods
Study participants and available measures. 
We used data from girls 6–11 years of age 
who participated in NHANES III, which 
collected data from 1988 through 1994. 
NHANES III is a cross-sectional, nationally 
representative survey with a complex multi-
stage clustered probability sampling design. 
Blacks and Mexican Americans were over-
sampled to provide more precise estimates for 
these groups, and children were sampled into 
the age categories < 6, 6–11, and 12–19 years. 
Study design details and data collection meth-
ods have been previously published (National 
Center for Health Statistics 1994).
We included 705 girls 6–11 years of age 
at the time of screening who participated in 
the household interview (44% of the 1,589 
girls in the 6- to 11-year age range) and who 
a) had a physical examination, including 
a standardized anthropometric assessment 
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Ba c k g r o u n d: Lead (Pb) and cadmium (Cd) are known reproductive toxicants thought to disrupt 
hormone production throughout sensitive developmental windows, although this has not been 
  previously examined in nationally representative peripubertal children.
oBjectives: We examined the association between blood Pb and urinary Cd concentrations and 
the reproductive hormones inhibin B and luteinizing hormone (LH) in girls 6–11 years of age 
who participated in the cross‑sectional Third National Health and Nutrition Examination Survey 
(NHANES III) (1988–1994).
Me t h o d s : Pb (micrograms per deciliter) was measured in whole blood, and Cd was measured in 
urine (nanograms per milliliter). Inhibin B (picograms per milliliter) and LH (milli–International 
units per milliliter) were measured in residual sera for 705 girls. Survey logistic regression was used 
to estimate associations with pubertal onset based on inhibin B concentration > 35 pg/mL or LH 
concentration > 0.4 mIU/mL, and multinomial logistic regression was used to estimate the associa‑
tion between Pb and increasing categories of hormone concentrations.
re s u l t s: High Pb (≥ 5 μg/dL) was inversely associated with inhibin B > 35 pg/mL [odds ratio 
(OR) = 0.26; 95% confidence interval (CI), 0.11–0.60; compared with Pb < 1 μg/dL]. At 10 and 
11 years of age, girls with low Pb (< 1 μg/dL) had significantly higher inhibin B than did girls with 
moderate (1–4.99 μg/dL) or high Pb (≥ 5 μg/dL). In the subsample of 260 girls with levels of inhibin B 
above the level of detection and using survey regression modeling, inhibin B levels were lower among 
girls with both high Pb and high Cd (β = –0.52; 95% CI, –0.09 to –1.04) than among girls with high 
Pb alone (β = –0.35; 95% CI, –0.13 to –0.57), relative to girls with low Pb and low Cd. 
co n c l u s i o n s: Higher Pb was inversely associated with inhibin B, a marker of follicular develop‑
ment, and estimated effects suggestive of pubertal delays appeared to be stronger in the context 
of higher Cd concentrations. These data underscore the importance of Pb and Cd as reproductive 
toxicants for young girls.
key w o r d s : heavy metals, inhibin B, luteinizing hormone, NHANES, puberty. Environ Health 
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(National Center for Health Statistics 1994), 
and b) had residual stored biospecimens for 
laboratory analysis. Blood was drawn from 
the children at the time of clinical examina-
tion according to NHANES III protocol and 
categorized as to timing of blood draw (morn-
ing, 0800–1200 hours; afternoon, 1200–1600 
hours; evening, 1600–1900 hours).
At 8–11 years of age, assessments were 
also made of pubertal status (Tanner 1962). 
Tanner staging for pubic hair and breast 
development classifies girls into progressive 
stages, ranging from stage 1 (no pubertal 
development) to stage 5 (fully mature). Using 
the NHANES III reliability data in a separate 
analysis, we determined that the reliability of 
Tanner staging was high [i.e., intraclass corre-
lation coefficient, 0.86; 95% confidence inter-
val (CI), 0.77–0.92; n = 44] for girls 8–11 
years of age. Nevertheless, Tanner staging was 
not a focus of the present study because this 
pubertal assessment was limited to children 
8–11 years of age, whereas hormone measure-
ments were available for all children 6–11 
years of age with available stored sera.
Several of the other relevant covariates 
were obtained from the NHANES III data-
base. Sociodemographic variables of interest 
included race/ethnicity (non-Hispanic white, 
non-Hispanic black, Mexican American, 
other), census region (Northeast, Midwest, 
South, West), metropolitan/nonmetropolitan 
residence, and the poverty–income ratio (PIR). 
The PIR was computed as the total household 
income divided by the poverty threshold for 
the year of the interview (U.S. Department 
of Agriculture, Food and Nutrition Service 
Financial  Management  and  Program 
Information Division 1987). The poverty 
threshold is determined annually by the U.S. 
Bureau of Census taking into account geo-
graphic location, rate of inflation, and family 
size. Based on the distribution of PIR (range, 
0–6.9; median, 1.3), we categorized it as < 1, 
1–2, and > 2, so that a higher PIR indicates 
better household financial status.
Other biological covariates examined as 
potential confounders included measures of 
iron deficiency, exposure to environmen-
tal tobacco smoke (Kolasa et al. 1998), and 
anthropometric measurements, which could 
affect both heavy metal body burden and 
pubertal development. Iron deficiency at exam-
ination was defined as two of three measures 
below age-specific cutoff values for transfer-
rin saturation, serum ferritin, and erythrocyte 
protoporphyrin according to the guidelines 
provided by the Centers for Disease Control 
and Prevention (CDC) (Looker et al. 1997). 
Because only two (< 0.1%) girls reported smok-
ing, we did not assess that exposure further, 
but we did assess the effect of environmental 
tobacco smoking exposure, which we defined 
as living with a cigarette smoker (yes/no).
Laboratory analysis. Pb was measured in 
whole blood (micrograms per deciliter), and 
Cd (nanograms per milliliter) was measured 
in urine using established standards of prac-
tice (Brody et al. 1994; Gunter et al. 1996). 
The spectrometric laboratory methods used 
by NHANES III to measure Pb and Cd 
are universally accepted methods that yield 
adequate sensitivity at lower detection levels 
and use small volumes of biological sample 
(Lemos and de Carvalho 2009). Nonfasting 
serum samples that were stored at –70°C 
were obtained from the National Center for 
Health Statistics/CDC, and hormonal assays 
(inhibin B and LH) were performed by Rules-
Based Medicine, Inc. (Austin, TX). Inhibin B 
was measured using the DSL-10-84100 
ACTIVE Inhibin B enzyme-linked immuno-
sorbent assay (ELISA; Gen I assay, Diagnostic 
Systems Laboratories, Inc., Webster, TX), an 
enzymatically amplified two-site two-step sand-
wich-type immunoassay with excellent internal 
validity [see Supplemental Material, Technical 
Note 1 (doi:10.1289/ehp.1001943)]; con-
centration was calculated from the standard 
curve. The functional sensitivity was a priori 
set at 7 pg/mL [i.e., limit of detection (LOD)] 
per manufacturer instructions. Because val-
ues below the LOD were not accessible, these 
were substituted uniformly with LOD/√
–
2. LH 
was measured using the LH ELISA kit (Bio-
Quant BQ049F; Bio-Quant, Inc., San Diego, 
CA), a solid-phase direct sandwich method 
[see Supplemental Material, Technical Note 1 
(doi:10.1289/ehp.1001943)]. The functional 
sensitivity (LOD) was set at 0.05 mIU/mL, 
and values below these levels were uniformly 
substituted with 0.035 mIU/mL, equivalent 
to LOD/√
–
2.
We chose a priori the hormone cutoffs 
that were most consistent with a pubertal 
individual given the limited available litera-
ture (inhibin B > 35 pg/mL and LH > 0.4 
mIU/mL) (Crofton et al. 2002; Houk et al. 
2009; Sehested et al. 2000; Teilmann et al. 
2007). We acknowledge that there are no 
universal criteria for setting cutoffs to dis-
criminate between pubertal stages given the 
known interindividual and intraindividual 
variance in hormone concentrations within a 
given pubertal stage.
Statistical analysis. We first used descrip-
tive statistics for assessing the completeness 
of data and, subsequently, potential selec-
tion bias. Specifically, we compared girls with 
regard to availability of stored sera (705, vs. 
884 without) in relation to select sociodemo-
graphic and anthropometric characteristics. 
Next, we compared characteristics of girls with 
hormone measurements by inhibin B con-
centrations dichotomized as being below or 
above an a priori determined cutoff consistent 
with puberty (> 35 pg/mL) (Crofton et al. 
2002; Sehested et al. 2000; Teilmann et al. 
2007). Statistical significance was formally 
assessed using the chi-square (two-sided) test 
for categorical variables and weighted regres-
sion for continuous variables; p-values < 0.05 
were considered significant and used for build-
ing the models. When comparing high and 
low inhibin B categories by anthropometric 
factors, we adjusted these measures for age 
for comparison to account for the strong age-
related changes associated with puberty.
We used both descriptive and analytic 
techniques to inspect and assess the data for 
the 705 girls for whom stored residual sera 
were available for hormone measurement of 
which 689 (98%) had sufficient sample for 
inhibin B analysis. We excluded 34 in the 
“other” racial ethnic group owing to their 
small numbers, leaving 671 for the LH analy-
sis and 655 for the inhibin B analysis. We 
used analysis of variance (ANOVA) to calcu-
late least-square mean inhibin B concentra-
tions (natural log transformed) by age and Pb 
categories for graphical presentation.
We used the survey procedures in SAS 
(version 9.1; SAS Institute Inc., Cary, NC) 
with sampling weights to account for the 
NHANES III complex sampling design to esti-
mate effects of blood Pb on inhibin B concen-
trations. Survey logistic regression was used 
to estimate the association between whole-
blood Pb and the prevalence of inhibin B (> 35 
pg/mL) and LH (> 0.4 mIU/mL) above the 
a priori cutoffs. Both continuous (log-trans-
formed) and categorical Pb variables (low Pb, 
< 1 μg/dL; moderate Pb, 1–4.9 μg/dL; and 
high Pb, ≥ 5 μg/dL) were modeled to account 
for the nonnormal distribution of blood Pb 
levels and evaluate potential nonlinearity. 
Although we are aware that Pb ≥ 5 μg/dL is 
not the conventional cutoff designating high 
Pb exposure, it was appropriate for our analy-
ses given the distribution of blood Pb levels in 
our sample.
In  complementary  analyses  [see 
Supplemental Material, Table 1 (doi:  10. 
1289/  ehp.1001943)], we used multi  nomial 
logistic regressions to estimate the association 
between continuous and categorical blood Pb 
(low, moderate, and high) and increasing cat-
egories of inhibin B [< LOD (60% of observa-
tions), medium (60–79th percentile), and high 
(≥ 80th percentile)] and LH [< LOD (48% 
of observations), medium (49–74th percen-
tile), and high (≥ 75th percentile)]. Factors 
that altered the coefficient for Pb in multi-
variable models by > 10% were retained in 
the final multivariable models. Based on this 
criterion, body mass index (BMI; kilograms 
per square meter), race/ethnicity (non-His-
panic black and Mexican-American indicators, 
with non-Hispanic white as referent), census 
region (Midwest, South, and West indicators, 
with Northeast as referent), and PIR (indica-
tors for categories < 1 and 1–2, with PIR > 2 as Gollenberg et al.
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referent) were retained in all final multivariable 
models, and age (in months) was retained in 
the logistic models.
In the 40% of girls with levels of inhibin B 
above the LOD, we estimated the effect of 
urinary Cd on inhibin B and LH using mul-
tivariable survey regression, with Cd catego-
rized into tertiles, using < LOD (automatically 
imputed as 0.01 ng/mL per NHANES III 
protocols; 33% of observations) as the refer-
ence level. We analyzed the effects of Cd and 
Pb classified as low Pb (< 5 μg/dL) and low 
Cd (first and second tertiles), low Pb and high 
Cd (third tertile), high Pb (≥ 5 μg/dL) and 
low Cd, and high Pb and high Cd. Likewise, 
we assessed the effects between moderate/high 
(≥ 1 μg/dL) and low Pb (< 1 μg/dL) and iron 
deficiency (yes/no). Although very few girls 
had iron deficiency in this sample, modeling 
was successful because the statistical weights 
allowed for estimation of category parameters.
Inhibin B did not demonstrate signifi-
cant diurnal variation based on the available 
categories of blood draw timing. LH is known 
to have diurnal variation, specifically, “sleep-
enhanced” variation near pubertal onset, but 
adjustment for timing of blood draw (morn-
ing, afternoon, evening) did not substantially 
alter associations among Pb, Cd, and LH.
Results
Our sample comprised 705 girls 6–11 years 
of age with complete anthropometry (all girls) 
and Tanner staging data (for girls 8–11 years 
of age). After excluding 34 girls of “other” 
race/ethnicity due to small numbers, 671 and 
655 girls had sufficient stored specimens avail-
able to measure LH and inhibin B, respec-
tively. Compared with girls without available 
stored biospecimens, the study sample was 
slightly younger (by 4 months, p = 0.03), less 
likely to be classified as Tanner breast stage 
≥ 3 (17% vs. 23%, p = 0.001) or non-His-
panic white (62% vs. 79%, p < 0.0001) or 
to live in a household with smokers (36% vs. 
45%, p = 0.005). Girls with available samples 
also had lower Pb concentrations than did 
those with available sera [mean (95% CI), 
0.7 μg/dL (0.6–0.9) vs. 0.9 μg/dL (0.8–1.02); 
p = 0.01]. Most anthropometric and hemato-
logic characteristics did not significantly differ 
between the groups (data not shown).
The mean inhibin B concentration was 
16.5 pg/mL [interquartile range (IQR), 4.95–
20.2 pg/mL], with 14% of girls exceeding 
the inhibin B cutoff value of 35 pg/mL and 
60% with values below the LOD. The mean 
LH concentration was 1.01 mIU/mL (IQR, 
0.035–1.07 pg/mL), with 36% exceeding the 
LH cutoff value of 0.4 mIU/mL and 48% 
with values below the LOD.
We noted several differences between 
girls with inhibin B concentrations below and 
above 35 pg/mL. Girls with concentrations 
above the cutoff were more likely to be older 
(p < 0.0001) and taller (p < 0.0001) and had 
lower average BMI (p = 0.01) than did girls 
with concentrations below the cutoff (Table 1). 
Girls with concentrations > 35 pg/mL were 
significantly more likely to be Tanner stage ≥ 2 
for both pubic hair and breast development 
and to live in the Northeast region (Table 2). 
The distribution of urinary Cd did not differ 
significantly by inhibin B, but girls with high 
inhibin B were more likely to have low blood 
Pb concentrations (13.5% vs. 28.4% < 1 
μg/dL for girls with low inhibin B; p = 0.06) 
(Table 2). In addition, girls with concentra-
tions > 35 μg/dL were somewhat less likely to 
have iron deficiency according to CDC criteria 
(0.1% vs. 1.8%, p = 0.09).
The median whole-blood Pb concentra-
tion was 2.5 μg/dL (range, 0.07–29.4 μg/dL) 
with only 14% (n = 93) falling between 5 
and 10 μg/dL and 5% (n = 32) exceed-
ing 10 μg/dL, the CDC level of concern 
for children (Bellinger 2008). The median 
urinary Cd concentration was 0.12 ng/mL 
(range, 0.01–3.38 ng/mL). Non-Hispanic 
black girls had higher age-  adjusted Pb lev-
els (mean = 3.2 μg/dL) than did non-His-
panic white girls (mean = 1.8 μg/dL) and 
Mexican-American girls (mean = 2.4 μg/dL; 
p < 0.0001). Similarly, non-Hispanic black 
girls were also more likely to have high Cd 
levels (fourth quartile; 31.6%) than were non-
  Hispanic white girls (21.7%) or Mexican-
American girls (18.3%; p = 0.002). Least-square 
mean values for inhibin B across the observed 
age range, by Pb category and controlling for 
race/ethnicity, indicate that older girls with 
low Pb measurements had higher inhibin B 
concentrations than did girls with moderate 
(1–4.99 μg/dL) or high Pb (≥ 5 μg/dL) meas-
urements (Figure 1).
The likelihood of exceeding the inhibin B 
pubertal cutoffs was significantly decreased 
in association with a one-unit increase in 
log-  transformed Pb concentration [adjusted 
odds ratio (OR) = 0.51; 95% CI, 0.34–0.78] 
Table 1. Anthropometric characteristics of study sample by serum inhibin B pubertal cut point (35 pg/mL).
Below Above
Characteristic n Weighted means (95% CI) n Weighted means (95% CI)
Age (years) 562 8.13 (8.00–8.25) 92 10.02 (9.70–10.34)
Height (cm) 563 134.1 (133.6–134.6) 92 137.1 (135.8–138.4)
Weight (kg) 561 32.9 (32.2–33.6) 92 32.1 (30.3–34.0)
BMI (kg/m2) 561 17.9 (17.6–18.1) 92 16.8 (16.1–17.6)
Age-adjusted least-square means and 95% CIs were calculated using weighted ANOVA.
Table 2. Distribution of sociodemographic and environmental characteristics by serum inhibin B pubertal 
cut point (35 pg/mL).
Below Above
Variable n Percent (95% CI) n Percent (95% CI) p-Value
Race/ethnicity
Non-Hispanic white 125 61.7 (51.2–72.3) 15 57.4 (45.7–69.1) 0.60
Non-Hispanic black 214 23.4 (15.9–30.9) 42 28.9 (19.8–38.1)
Mexican American 224 14.9 (9.6–20.1) 35 13.7 (6.8–20.6)
PIR
< 1 216 27.2 (19.3–35.2) 46 29.3 (18.7–39.9) 0.80
1–2 137 24.7 (18.5–30.8) 19 20.5 (12.9–27.9)
> 2 163 48.2 (38.4–57.7) 24 50.3 (36.1–64.6)
Census region
Northeast 38 11.1 (4.1–18.1) 9 23.0 (17.4–28.3) < 0.0001
Midwest 118 24.6 (15.6–33.6) 26 42.9 (30.2–55.3)
South 225 37.6 (23.6–51.6) 36 21.4 (13.0–29.5)
West 182 26.7 (11.4–42.1) 21 13.1 (8.0–18.3)
Blood Pb (µg/dL)
< 1 53 13.6 (7.6–19.5) 16 28.4 (10.4–46.6) 0.06
1–4.99 397 72.9 (66.1–79.6) 61 61.7 (43.3–79.9)
≥ 5 111 13.6 (7.7–19.5) 14 9.9 (6.5–13.3)
Urinary Cd (ng/mL)
0.01–0.01 175 37.7 (29.8–45.6) 30 37.2 (21.0–53.4) 0.80
0.03–0.26 236 39.5 (31.7–47.4) 37 33.1 (13.5–52.8)
0.27–3.38 120 22.8 (18.0–27.5) 20 29.7 (6.1–53.3)
Pubic hair Tanner stage
1 178 65.9 (57.1–74.8) 12 21.0 (11.2–30.9) < 0.0001
2 66 19.9 (14.6–25.2) 24 31.3 (13.1–49.5)
≥ 3 63 14.2 (8.5–19.9) 36 47.7 (20.4–75.0)
Breast Tanner stage
1 166 61.3 (51.7–71.0) 9 22.2 (12.4–32.0) < 0.0001
2 89 27.5 (18.5–36.6) 28 34.1 (15.9–52.4)
≥ 3 57 11.2 (6.4–15.9) 36 43.7 (16.4–70.9)Lead, cadmium, and hormones in peripubertal girls
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(Table 3). Adjusted ORs for exceeding the 
pubertal threshold for inhibin B were 0.38 
(95% CI, 0.12–1.15) and 0.26 (95% CI, 
0.11–0.60) for girls with moderate and 
high Pb levels, respectively, compared with 
low levels. Adjustment for age, race/ethnic-
ity, BMI, PIR, and census region tended to 
strengthen the magnitude of association away 
from the null.
Fifty-two percent of the 705 girls had 
detectable levels of LH, with 36% (n = 252) 
exceeding the pubertal cutoff value of 
0.4 mIU/mL. Pb ≥ 5 μg/dL was inversely 
(though nonsignificantly) associated with LH 
above the cutoff [adjusted OR = 0.98 (95% 
CI, 0.48–1.99) and 0.83 (95% CI, 0.37–1.87) 
for moderate and high vs. low Pb, respec-
tively]. Pb was not significantly associated with 
continuous LH concentrations before or after 
adjustment (data not shown).
Models examining the likelihood of 
exceeding increasing percentile categories for 
inhibin B and LH by blood Pb produced simi-
lar and confirmatory results [see Supplemental 
Material, Table 1 (doi:10.1289/ehp.1001943)], 
with significant inverse associations with blood 
Pb that were stronger for higher categories of 
inhibin B concentration and weaker nonsignifi-
cant associations with categories of LH concen-
trations. High Pb (≥ 5 μg/dL) compared with 
low Pb (< 1 μg/dL) was strongly inversely asso-
ciated with having inhibin B ≥ 80th percentile 
compared with below the LOD (OR = 0.31; 
95% CI, 0.12–0.83) but only moderately 
inversely associated with inhibin B between 
the 60th and 79th percentiles compared with 
below the LOD (OR = 0.70; 95% CI, 0.30–
1.60). For LH, high Pb (≥ 5 μg/dL) compared 
with low Pb (< 1 μg/dL) was inversely asso-
ciated with LH ≥ 75th percentile compared 
with below the LOD (OR = 0.48; 95% CI, 
0.19–1.22), although not significantly so.
Urinary Cd (continuous or categorical) 
was not significantly associated with inhibin B 
or LH concentrations (data not shown). 
However, in the 40% of girls with inhibin B 
levels above the LOD, the inverse association 
with inhibin B concentrations was stronger 
for girls with high Cd and high Pb than for 
those with high Pb alone, with reference to 
girls with both low Pb and low Cd (Table 4). 
We also found a significant effect of iron defi-
ciency and moderate/high Pb on inhibin B 
concentrations. Girls with moderate/high Pb 
(≥ 1 μg/dL) and iron deficiency had a signifi-
cantly lower log inhibin B (β = –0.84; 95% 
CI, –0.39 to –1.29). In other words, the iron-
deficient girls with even moderate levels of Pb 
exposure had even lower inhibin B concentra-
tions than did iron-sufficient girls with mod-
erate/high Pb concentrations (Table 4).
A sensitivity analysis restricted to girls 
with Pb levels < 10 μg/dL produced com-
parable results, although ORs were slightly 
attenuated. Given that girls with higher 
inhibin B tended to be slightly taller and 
thinner than girls with lower inhibin B, we 
explored an alternative hypothesis relating 
to reverse causality with regard to height. 
However, adjustment for height did not sub-
stantially alter the observed associations [see 
Supplemental Material, Technical Note 2 
(doi:10.1289/ehp.1001943)].
Discussion
As far as we are aware, this is the first study 
to identify a possible hormonal pathway by 
which Pb may delay pubertal onset and/or 
progression among girls participating in the 
NHANES III survey. Specifically, we observed 
that at older ages, girls with higher blood Pb 
concentrations had lower levels of inhibin B, 
and this was apparent even among girls whose 
Pb concentrations were below the 10-μg/dL 
value cited by the CDC as indicative of signif-
icant exposure in children. Additionally, hav-
ing high Cd in addition to high Pb appeared 
to have an even greater impact on inhibin B 
levels than did high Pb alone. Two other 
noteworthy findings were that a) inhibin B 
levels were lowest for iron-deficient girls with 
moderate/high Pb levels, suggesting that Pb 
may be particularly toxic in iron-deficient 
girls, and b) there were racial/ethnic differ-
ences in Pb and Cd concentrations. Our 
findings add to a growing body of literature 
on the reproductive effects of environmental 
Pb and Cd exposure and extend the body of 
evidence to a large nationally representative 
sample of peripubertal girls.
Figure 1. Inhibin B by whole-blood Pb level categories for girls, 6–11 years of age, from NHANES III, 
1988–1994. Bars indicate least-square means, controlling for race/ethnicity; errors bars indicate 95% CIs.
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Table 3. Association between blood Pb and odds of exceeding the inhibin B cutoff using weighted survey 
logistic regression.
Variable n OR (95% CI) Unadjusted Multivariable adjusteda
Continuous Pb
Log Pb 668 0.58 (0.36–0.95) 0.51 (0.34–0.78)
Categorical Pb
Low, < 1 µg/dL 72 Reference Reference
Moderate, 1–4.9 µg/dL 470 0.40 (0.14–1.15) 0.38 (0.12–1.15)
High, ≥ 5 µg/dL  126 0.35 (0.14–0.87) 0.26 (0.11–0.60)
aAdjusted for age (months), race/ethnicity (non-Hispanic white as referent), BMI (kg/m2), PIR (> 2 as referent), and cen-
sus region (Northeast as referent).
Table 4. Effects of blood Pb and urinary Cd concentration, blood Pb, and iron deficiency on (natural log) 
inhibin B levels in 260 girls with inhibin B levels > LOD using weighted regression modeling.
β-Valuea (95% CI) p-Value
Pb/Cd category (n = 260)
Low Pb (< 5 µg/dL) and low Cd (first and second tertiles) Reference
Low Pb (< 5 µg/dL) and high Cd (third tertile) 0.17 (–0.15 to 0.50) 0.29
High Pb (≥ 5 µg/dL) and low Cd (first and second tertiles) –0.35 (–0.13 to –0.56) 0.002
High Pb (≥ 5 µg/dL) and high Cd (third tertile) –0.52 (–0.07 to –0.97) 0.02
Pb /iron deficiency category (n = 260)
Low Pb (< 1 µg/dL) and iron sufficient Reference
Low Pb (< 1 µg/dL) and iron deficient –0.11 (0.32 to –0.53) 0.61
Moderate/high Pb (≥ 1 µg/dL) and iron sufficient –0.39 (–0.06 to –0.71) 0.02
Moderate/high Pb (≥ 1 µg/dL) and iron deficient –0.84 (–0.37 to –1.31) 0.0008
aAdjusted for race/ethnicity (non-Hispanic white as referent), BMI (kg/m2), PIR (> 2 as referent), and census region 
(Northeast as referent).Gollenberg et al.
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In previous studies, blood Pb has been 
associated with later menarche in 1,706 
girls 8–16 years of age who participated in 
NHANES III (Wu et al. 2003), and with 
later menarche among 138 Akwesasne girls 
10–16.9 years of age (Denham et al. 2005). 
However, a smaller study of 87 9-year-old 
girls in New York City did not find an asso-
ciation between blood Pb and Tanner stage (1 
vs. ≥ 2) (Wolff et al. 2008).
Animal studies are also consistent in find-
ing that rats exposed to Pb have decreased LH 
and estradiol concentrations and a delay in 
sexual maturation (Dearth et al. 2002, 2004). 
Other studies have reported that Pb is associ-
ated with a dose-related delay in time to vagi-
nal opening and decreased estradiol levels at 
puberty in rats exposed to environmentally rel-
evant doses of Pb (Ronis et al. 1998a, 1998b).
The observed inverse association between 
Pb and inhibin B, a marker of follicular devel-
opment through the peripubertal stages, adds 
further evidence that Pb may be associated 
with a delay of pubertal onset and the tim-
ing of its course. It has been hypothesized that 
reproductive and growth effects of Pb may 
involve multiple endocrine pathways (Ronis 
et al. 1996). A delicate balance of hypotha-
lamic, pituitary, adrenal, and gonadal hor-
mones and growth factors regulates the onset 
and tempo of sexual development, including 
multiple feedback mechanisms within the 
hypothalamic–pituitary–gonadal and hypo-
thalamic–pituitary–adrenal axes, and then the 
onset is followed by a surge of gonadotropin 
secretion paralleling ovarian follicular develop-
ment [reviewed by Buck Louis et al. (2008)]. 
Given that inhibin B is produced by the granu-
losa cells in the ovary (Hillier and Miro 1993), 
our results suggest that Pb may act directly at 
the level of the ovary, as well as acting through 
feedback mechanisms at the hypothalamic–
pituitary level. In contrast, our results do not 
suggest that LH is affected by blood Pb at 
these ages, but an association between Pb and 
LH could be obscured due to interindividual 
and intraindividual variation in LH concentra-
tions in this age group at or around the time of 
puberty (Manasco et al. 1997).
To our knowledge, there have been no pre-
vious studies of urinary Cd concentrations in 
relation to puberty timing in girls. In labora-
tory animals, Cd exposure has been associated 
with a decrease in estradiol (Zhang et al. 2008) 
and in LH and follicle-stimulating hormone 
(Paksy et al. 1989; Pillai et al. 2003). Cd also 
is known to accumulate in the granulosa cells 
of the ovary (Nampoothiri and Gupta 2006). 
It has been proposed that coexposure to Pb 
and Cd might exert a synergistic detrimental 
effect on reproductive performance in human 
pregnancy (Nampoothiri and Gupta 2006, 
2008). Pb and Cd may act through similar 
physiologic and metabolic pathways, because 
both metals interact with and displace zinc 
and iron in different chemical reactions (Goyer 
1997). Our finding that coexposure to higher 
levels of both Pb and Cd was associated with 
decreased inhibin B is consistent with the few 
animal studies of synergistic effects of Cd and 
Pb on hypothalamic–pituitary–adrenal func-
tion (Pillai et al. 2003; Tapisso et al. 2009) 
and their effects on bioavailability in humans 
(Dunicz-Sokolowska et al. 2006; Komjarova 
and Blust 2008; Osman et al. 1998). However, 
there is a paucity of research on the joint effects 
of metal mixtures on health outcomes, even 
though human exposure to metal mixtures 
occurs more often than exposure to isolated 
metals (Choudhury and Mudipalli 2008).
The observed effect of blood Pb ≥ 1 μg/dL, 
iron deficiency, and decreased inhibin B was 
striking. Although few girls in this U.S. sample 
were actually iron deficient, it is concerning 
that effects were apparent even at moderate 
levels of Pb exposure. It is known that children 
with high Pb exposure are also more likely to 
be iron deficient (Tripathi et al. 2001) and that 
gastrointestinal absorption of both Pb and Cd 
is increased in the presence of low iron stores 
(Goyer 1997; Osman et al. 1998; Tripathi et al. 
2001). An effect of Pb and iron deficiency on 
inhibin B concentrations is plausible, given that 
both factors are known to independently affect 
health and cognition of children (Kordas et al. 
2004). Iron-deficiency screening may be an 
important factor to consider as a part of blood 
Pb screening in at-risk populations and may be 
particularly important in less developed coun-
tries where the prevalence of iron deficiency is 
substantially higher than in the United States.
Environmental  Pb  exposure  has 
decreased after implementation of the Lead 
Contamination Control Act of 1988 (amend-
ment to the Safe Drinking Water Act) and leg-
islation banning the sale of leaded gasoline for 
use in on-road vehicles, although children con-
tinue to have detectable levels of blood Pb, espe-
cially children from certain minority groups, 
low-  income households, and internationally 
adopted children (CDC 2005). Consequently, 
sub  sequent national surveys probably will have 
relatively lower average Pb concentrations and 
may be less suited to address this etiologic 
question. The CDC cites Pb concentrations 
≥ 10 μg/dL for toxic levels, yet health effects of 
neurodevelopmental deficits and growth impair-
ments are observed for even modest levels of 
Pb, calling into question the existing threshold 
(Bellinger 2008; Ha et al. 2009). Furthermore, 
environmental Pb contamination remains a 
significant public health problem in develop-
ing countries. Pb concentrations in children 
from such locations as Mexico, India, Russia, 
and China are reported to be well above the 
CDC’s recommended threshold, with a range 
of 1–13% above the blood Pb threshold level of 
10 μg/dL (CDC 2000; Tripathi et al. 2001).
NHANES III is a nationally representative 
sample of U.S. residents, making our results 
likely generalizable to the underlying U.S. 
population of girls who were 6–11 years of 
age between 1988 and 1994. However, our 
analytic sample comprised a subset of partici-
pants with stored sera available for additional 
laboratory analyses. Although we observed 
some differences between our study sample 
and those we excluded due to insufficient sera, 
including a slightly younger age and fewer 
non-Hispanic white girls, there is no reason to 
believe that the observed associations between 
Pb and inhibin B would differ substantially 
if we had included the entire NHANES III 
population. In fact, girls without stored sera 
had slightly higher mean blood Pb levels than 
did girls with stored sera, suggesting that the 
observed association between Pb and inhibin B 
would in fact have been more statistically sig-
nificant because of increased statistical power 
if the entire population had been analyzed for 
a dose–response association. Furthermore, this 
study represents the largest study to date with 
hormonal measurements as markers of puber-
tal development in U.S. girls.
A limitation of this analysis includes the 
cross-sectional nature of the NHANES III 
data collection. Future studies should exam-
ine longitudinal hormone measurements to 
determine if Pb is associated with a delay in 
the increase of inhibin B and other hormonal 
markers consistent with the onset of puberty. 
Because of the limited amount of residual sera, 
we also were unable to measure additional 
hormones, such as estradiol and follicle-stim-
ulating hormone, which might add further 
insight into the mechanism by which Pb may 
be associated with pubertal delay. Second, we 
cannot exclude the possibility that Pb and Cd 
exposures during prenatal, postnatal, or early 
childhood ages may explain or contribute 
to the observed decrease in inhibin B levels, 
rather than the levels observed at 6–11 years 
of age. Finally, we were compelled to esti-
mate the magnitude of associations between 
Pb and the hormone cutoffs primarily using 
multinomial and logistic regression analyses 
because so many young girls at these ages had 
hormone levels below the LODs. We were 
thereby limited in our ability to detect subtle 
or linear effects (Schisterman et al. 2006).
Conclusion
Our findings suggest a possible hormonal 
pathway by which blood Pb is associated with 
delayed onset and/or progression of puberty, 
that is, through a reduction in serum inhibin B 
or possibly through an interaction with Cd. 
Despite relatively low blood Pb levels in this 
sample of U.S. girls, we observed associations 
with pubertal hormonal markers, underscor-
ing the importance of further efforts to reduce 
environmental Pb and Cd exposures.Lead, cadmium, and hormones in peripubertal girls
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